Literature DB >> 25400792

Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels.

Shogo Tajima1, Michihiko Waki2, Tomonori Tsuchiya3, Shoji Hoshi1.   

Abstract

Granulocyte colony-stimulating factor (G-CSF)-producing tumors are known for their aggressive behavior. Only four cases of G-CSF-producing colorectal carcinoma have been previously reported. Herein, we present a case of an undifferentiated carcinoma of the descending colon showing G-CSF production and giant cell carcinoma morphology in a 93-year-old woman. A tumor with a diameter of 80 mm was identified in the descending colon via computed tomography. Descending colectomy was performed involving the abdominal wall where tumor invasion was observed. The white blood cell count, which was elevated before resection, decreased to normal levels after intervention. However, local recurrence at the resected site was detected 39 days after surgery. Upon recurrence, increased white blood cell counts and serum G-CSF were seen. The patient died because of respiratory failure 98 days after colectomy. By using immunohistochemistry, G-CSF expression was detected in tumor cells in the resected specimen, along with overexpression of CD44 and highly proliferating nestin-positive tumor vessels. The poor clinical outcome of this patient is consistent with previous reports that the expression of these three molecules predict poor prognosis. While G-CSF can be a therapeutic target considering its auto/paracrine function to induce tumor growth via the G-CSF receptor, CD44 and nestin may also be possible candidate therapeutic targets. Further studies are required to assess the efficacy of treatments targeting these three molecules.

Entities:  

Keywords:  CD44; Colon; giant cell carcinoma; granulocyte colony-stimulating factor; nestin; undifferentiated carcinoma

Mesh:

Substances:

Year:  2014        PMID: 25400792      PMCID: PMC4230158     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

Review 1.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

2.  Aggressive undifferentiated colon carcinoma producing granulocyte-colony stimulating factor: report of a case.

Authors:  Akihisa Matsuda; Koji Sasajima; Takeshi Matsutani; Hiroshi Maruyama; Masayuki Miyamoto; Tadashi Yokoyama; Seiji Suzuki; Hideyuki Suzuki; Takashi Tajiri
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

3.  Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor.

Authors:  Kazuya Endo; Shunji Kohnoe; Takeshi Okamura; Masaru Haraguchi; Eisuke Adachi; Yasushi Toh; Hideo Baba; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

Review 4.  Jaks and Stats in signaling by the cytokine receptor superfamily.

Authors:  J N Ihle; I M Kerr
Journal:  Trends Genet       Date:  1995-02       Impact factor: 11.639

5.  Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis.

Authors:  K Kojima; F Nakashima; A Boku; Y Muroishi; I Nakanishi; Y Oda
Journal:  Histol Histopathol       Date:  2002-10       Impact factor: 2.303

6.  Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.

Authors:  T Tanaka; S Jiang; H Hotta; K Takano; H Iwanari; K Sumi; K Daigo; R Ohashi; M Sugai; C Ikegame; H Umezu; Y Hirayama; Y Midorikawa; Y Hippo; A Watanabe; Y Uchiyama; G Hasegawa; Pc Reid; H Aburatani; T Hamakubo; J Sakai; M Naito; T Kodama
Journal:  J Pathol       Date:  2006-04       Impact factor: 7.996

7.  p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer.

Authors:  Darjus F Tschaharganeh; Wen Xue; Diego F Calvisi; Matthias Evert; Tatyana V Michurina; Lukas E Dow; Ana Banito; Sarah F Katz; Edward R Kastenhuber; Susann Weissmueller; Chun-Hao Huang; Andre Lechel; Jesper B Andersen; David Capper; Lars Zender; Thomas Longerich; Grigori Enikolopov; Scott W Lowe
Journal:  Cell       Date:  2014-07-31       Impact factor: 41.582

8.  Role and prognostic significance of CD44s expression in colorectal cancer.

Authors:  Paolo Visca; Franca Del Nonno; Claudio Botti; Ferdinando Marandino; Valeria Sebastiani; Ugo Di Tondo; Raffaele Perrone Donnorso; Giorgio Trombetta; Stefania Filippi; Piero Luigi Alo
Journal:  Anticancer Res       Date:  2002 Sep-Oct       Impact factor: 2.480

9.  Granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma following chemoradiotherapy and bone marrow transplantation for acute lymphoblastic leukemia.

Authors:  Shuhei Mayanagi; Masahiro Niihara; Hironobu Goto; Tomoya Yokota; Hiroyuki Tabuse; Hiroshi Yasui; Hirofumi Ogawa; Tetsuo Nishimura; Kimihide Kusafuka; Yasuhiro Tsubosa
Journal:  Esophagus       Date:  2013-08-28       Impact factor: 4.230

10.  Prognostic role of CD133 expression in colorectal cancer: a meta-analysis.

Authors:  Ke Wang; Jianjun Xu; Junshu Zhang; Jian Huang
Journal:  BMC Cancer       Date:  2012-12-05       Impact factor: 4.430

View more
  2 in total

1.  Granulocyte-colony stimulating factor producing anaplastic carcinoma of the pancreas treated by distal pancreatectomy and chemotherapy: report of a case.

Authors:  Hiroaki Kitade; Hidesuke Yanagida; Masanori Yamada; Sohei Satoi; Kazuhiko Yoshioka; Nobuaki Shikata; Masanori Kon
Journal:  Surg Case Rep       Date:  2015-05-30

2.  Pleomorphic Carcinoma of the Colon: Morphological and Immunohistochemical Findings.

Authors:  Giovanni Branca; Valeria Barresi; Antonio Ieni; Eleonora Irato; Rosario Alberto Caruso
Journal:  Case Rep Gastroenterol       Date:  2016-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.